R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

JP Morgan 2023 - Day 1

We’re preparing to start JP Morgan week with a busy day Monday, with day 1 of the Informa Biotech Showcase, including a dedicated mini-event on Cell and Gene Therapy in the morning.

R&D

JP Morgan 2023 – Pre event

Before the main event at JP Morgan 2023 even kicks off, we’re checking out the Sachs Associates Neuroscience Innovation Forum on Sunday.

R&D

pharmaphorum launches The World Without Disease Summit – Jun...

pharmaphorum is proud to announce its inaugural “The World Without Disease Summit”: a high quality, two-day event bringing together key global leaders and innovators to explore the potentia

R&D

6 research and development life science predictions for 2023

From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables life sciences tea

R&D

JP Morgan 2023

For most people, the name “JP Morgan” means bankers and investors.

R&D

With landmark approval, spotlight on cryogenic logistics int...

The cell and gene therapy (CGT) industry achieved a significant milestone at the end of 2022: the first approval of an allogeneic T-cell therapy in the world.